30 April 2020: We amended recommendation 8.5 to include a link to UK government guidance on re-using medicines in care homes and hospices during the COVD-19 pandemic. We also made minor changes for clarification in recommendations 8.2 and 8.3.
22 April 2020: We amended recommendation 5.4 and table 2 to include ibuprofen as an option for managing fever and other symptoms that antipyretics would help treat. This is in line with our evidence summary on acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 and an NHS England policy on acute use of NSAIDs in people with or at risk of COVID-19. We also clarified the source of prescribing data in tables 4, 5 and 6.
17 April 2020: We linked to support for off-label prescribing from the GMC and CQC in recommendation 6.5 and the notes under tables 4 and 5. We also removed the antiemetic and laxative examples from these tables. We clarified tables 5 and 6 to highlight that the dose may need to be adjusted in some patients.
Minor changes since publication
26 May 2020: We updated the list of symptoms in recommendation 1.1 to include loss of smell or taste in line with current government advice.